PAULE, I., TOD, M., HENIN, E., YOU, B., FREYER, G., & GIRARD, P. (2012). Dose adaptation of capecitabine based on individual prediction of limiting toxicity grade: evaluation by clinical trial simulation. Cancer Chemotherapy and Pharmacology, 69(2), 447-455.

PAULE, Ines, TOD, Michel, HENIN, Emilie, YOU, Benoit, FREYER, Gilles und GIRARD, Pascal, 2012. Dose adaptation of capecitabine based on individual prediction of limiting toxicity grade: evaluation by clinical trial simulation. Cancer chemotherapy and pharmacology. 1 Januar 2012. Vol. 69, no. 2, p. 447-455.

PAULE, I., M. TOD, E. HENIN, B. YOU, G. FREYER, und P. GIRARD. „Dose Adaptation of Capecitabine Based on Individual Prediction of Limiting Toxicity Grade: Evaluation by Clinical Trial Simulation“. Cancer Chemotherapy and Pharmacology, Bd. 69, Nr. 2, Januar 2012, S. 447-55.

PAULE, Ines/TOD, Michel/HENIN, Emilie/YOU, Benoit/FREYER, Gilles/GIRARD, Pascal: Dose adaptation of capecitabine based on individual prediction of limiting toxicity grade: evaluation by clinical trial simulation, Cancer chemotherapy and pharmacology 2012, 447-455.

PAULE, I., TOD, M., HENIN, E., YOU, B., FREYER, G. und GIRARD, P. (2012), „Dose adaptation of capecitabine based on individual prediction of limiting toxicity grade: evaluation by clinical trial simulation“, Cancer Chemotherapy and Pharmacology, Vol. 69 No. 2, S. 447-455.